 |
|
Natural History of Schizophrenia SubtypesI. Longitudinal Study of Paranoid, Hebephrenic, and Undifferentiated Schizophrenia
Wayne S. Fenton, MD;
Thomas H. McGlashan, MD
Arch Gen Psychiatry. 1991;48(11):969-977.
Abstract
| |
• To explore the validity of different approaches for subtyping schizophrenia, the conditions of 187 schizophrenic patients from the Chestnut Lodge follow-up study were rediagnosed with the use of classic subtype criteria. Independently collected data allowed construction of a longitudinal profile of the natural history of illness for patients who met operational criteria for paranoid (n = 78), hebephrenic (n = 26), and undifferentiated (n = 83) schizophrenia. Paranoid schizophrenia had an older age at onset, often developed rapidly in individuals with good premorbid functioning, tended to be intermittent during the first 5 years of illness, and was most associated with good outcome or recovery. Hebephrenia had an earlier age at onset, often developed insidiously, and was associated with a greater family history of psychopathology, poor premorbid functioning, and, frequently, a continuous illness with a poor long-term prognosis. While also early and insidious in onset, unlike hebephrenia, undifferentiated schizophrenia was poorly distinguished from the patients' premorbid state, associated with an early history of behavioral difficulties, and often resulted in a continuous but stable disability. We discuss implications for nosology. Although distinctive patterns were discernible, the considerable heterogeneity within subtypes calls for continued efforts to develop and explore alternate classification schemes.
Author Affiliations
From the Chestnut Lodge Research Institute, Rockville, Md (Dr Fenton); and Yale Psychiatric Institute, New Haven, Conn (Dr McGlashan).
Footnotes
Accepted for publication May 17, 1990.
Reprint requests to Chestnut Lodge Research Institute, 500 W Montgomery Ave, Rockville, MD 20850 (Dr Fenton).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Wayne Fenton, M.D.
Stover, and Insel
Am. J. Psychiatry 2008;165:177-178.
FULL TEXT
Identifying Unmet Therapeutic Domains in Schizophrenia Patients: The Early Contributions of Wayne Fenton From Chestnut Lodge
McGlashan and Carpenter
Schizophr Bull 2007;33:1086-1092.
ABSTRACT
| FULL TEXT
Clinical detection of schizophrenia-prone individuals: Critical appraisal
PARNAS
Br. J. Psychiatry 2005;187:s111-s112.
ABSTRACT
| FULL TEXT
First-Episode Psychosis: Psychopathology, Quality of Life, and Functional Outcome
Malla and Payne
Schizophr Bull 2005;31:650-671.
ABSTRACT
| FULL TEXT
Schizophrenia and Other Psychotic Disorders
Jibson et al.
Focus 2004;2:17-30.
ABSTRACT
| FULL TEXT
Suicide and schizophrenia
Siris
J Psychopharmacol 2001;15:127-135.
ABSTRACT
Schizophrenia as a Disorder of Developmentally Reduced Synaptic Connectivity
McGlashan and Hoffman
Arch Gen Psychiatry 2000;57:637-648.
ABSTRACT
| FULL TEXT
Clinical Risk Following Abrupt and Gradual Withdrawal of Maintenance Neuroleptic Treatment
Viguera et al.
Arch Gen Psychiatry 1997;54:49-55.
ABSTRACT
A Longitudinal Study of Symptom Dimensions in Schizophrenia: Prediction and Patterns of Change
Arndt et al.
Arch Gen Psychiatry 1995;52:352-360.
ABSTRACT
Signs and Symptoms: What Can They Tell Us About the Clinical Course and Pathophysiologic Processes of Schizophrenia?
Lieberman
Arch Gen Psychiatry 1995;52:361-363.
ABSTRACT
Neuroleptic Withdrawal in Schizophrenic Patients
Baldessarini et al.
Arch Gen Psychiatry 1995;52:189-192.
ABSTRACT
Risk Factors for Spontaneous Dyskinesia in Schizophrenia
Fenton et al.
Arch Gen Psychiatry 1994;51:643-650.
ABSTRACT
Testing Systems for Assessment of Negative Symptoms in Schizophrenia
Fenton and McGlashan
Arch Gen Psychiatry 1992;49:179-184.
ABSTRACT
|
